Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Megestrol Acetate × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 10 Breast 4 Tumor-Agnostic 1 Sarcoma 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1 CNS 1

Conditions

Adrenocortical Carcinoma 1

Interventions

Everolimus 25 lutetium Lu 177 dotatate 22 Temozolomide 21 pembrolizumab 19 Cisplatin 14 lenvatinib 13 cabozantinib 13 Nivolumab 13 Magnetic Resonance Spectroscopy 13 Capecitabine 13 Sunitinib 12 Bevacizumab 12 Specimen Handling 11 Sorafenib 9 Etoposide 9 trametinib 8 pasireotide 8 dabrafenib 8 Paclitaxel 8 Ipilimumab 8 lanreotide 7 Octreotide 7 Carboplatin 7 pazopanib 6 Irinotecan 6 Injections 6 gallium Ga 68 dotatate 5 Mitotane 5 Fluorodeoxyglucose F18 5 surufatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡